Citation

Susan Fiscus , Yacine Saidi , Eleni Nastouli , Lynda Harper , Alexandra Compagnucci , Abdel Babiker , Ross McKinney , Diana Gibb , Gareth Tudor-Williams , the PENPACT-1 (PENTA 9/PACTG 390) Study Team, Linda Harrison, Ann Melvin. HIV-1 Drug Resistance and Second-line Treatment in Children Randomized to Switch at Low versus Higher RNA Thresholds. Journal of Acquired Immune Deficiency Syndromes. 2015. 70: 42-53. PMID: 26322666

Citation

Kaitlin Rainwater-Lovett, Carrie Ziemniak, Katherine Luzuriaga, Edmund V. Capparelli, Gayane Yenokyan, Deborah Persaud, Priyanka Uprety, Ellen G. Chadwick. Cell-Associated HIV-1 DNA and RNA Decay Dynamics during Early Combination Antiretroviral Therapy in HIV-1-Infected Infants. Clinical Infectious Diseases. 2015. 15: 1862-70. PMID: 26270687

Citation

T Fenton, CV Fletcher, JJ Kiser, Mofenson LM, E Smith, B Graham, M Mathew, G Aldrovani, PACTG 1020A Study Team, RM Rutsein, P Samson. Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A.. Pediatric Infectious Disease Journal. 2015. 34: 162-167. PMID: 25232777

Citation

Miriam Chernoff, Mark J Abzug, Myron J Levin, George R Seage III, James M Oleske, Murli U Purswani, Rohan Hazra, Shirley Traite, Bonnie Zimmer, Russell B Van Dyke, Gayatri Mirani, Paige L Williams, IMPAACT P1074 Study Team. Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy. Clinical Infectious Diseases. 2015. 61: 1850-61. PMID: 26270680

Citation

SH Vermund. Screening for Sexually Transmitted Infections in Antenatal Care is Especially Important Among HIV-infected Women. Sexually Transmitted Diseases. 2015. 42: 566-568. PMID: 26372928

Citation

Jiahong Xu, Jorge Pinto, Bonnie Ank, Marisa Mussi-Pinhata, Claire C. Bristow, Mariana Ceriotto, Mariza G Morgado, Daisy Maria Machado, D. Heather Watts, Yvonne J Bryson, Fred Weir, Beatriz Grinsztejn, David Persing, Francisco I Bastos, Lynne M. Mofenson, George Siberry, Valdilea G. Veloso, Karin Neilsen-Saines for the NICHD HPTN 040 Study Team, Jose Henrique Pilotto, Esau Joao, Glenda Gray, Gerhard Theron, Breno Santos, Kristina Adachi, Rosana Fonseca, Jeffrey D Klasner, Regis Kreitchmann. Chlamydia and Gonorrhea in HIV-infected Pregnant Women and Adverse Infant Outcomes. Sexually Transmitted Diseases. 2015. 42: 554-65. PMID: 26372927

Citation

EP Acosta, H Teppler, B Homony, B Graham, T Fenton, X Xu, ML Rizk, SA Spector, LM Frenkel, C Worrell, E Handelsman, A Wiznia, S Nachman, C Alvero. Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of Age. Journal of Pediatric Infectious Disease Society. 2015. 4: e76-83. PMID: 26582887

Citation

C Bennetto-Hood, L Wenning, H Teppler, B Homony, B Graham, C Fry, S Nachman, A Wiznia, C Worrell, B Smith, EP Acosta, ML Rizk, L Du. Population Pharmacokinetic Analysis of Raltegravir Pediatric Formulations in HIV-infected Children 4 weeks to 18 years of age. 2015. PMID: 25753401

Citation

Deborah Kacanek, Michael D Hughes, Arlene Bardeguez, Elizabeth Livingston, Alice Stek, David E Shapiro, Ruth Tuomala, Ingrid T Katz, Erin Leister. Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study. Annals of Internal Medicine. 2015. 162: 90-99. PMID: 25599347